Inhaled triple therapy and airway hyperresponsiveness in persistent asthma
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:126 |
|---|---|
| Enthalten in: |
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology - 126(2021), 5 vom: 01. Mai, Seite 597-598 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lipworth, Brian [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
3OWL53L36A |
|---|
| Anmerkungen: |
Date Completed 19.05.2021 Date Revised 19.05.2021 published: Print-Electronic ClinicalTrials.gov: NCT02682862 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.anai.2021.01.032 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321090128 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321090128 | ||
| 003 | DE-627 | ||
| 005 | 20231225175055.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.anai.2021.01.032 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1070.xml |
| 035 | |a (DE-627)NLM321090128 | ||
| 035 | |a (NLM)33548471 | ||
| 035 | |a (PII)S1081-1206(21)00094-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lipworth, Brian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Inhaled triple therapy and airway hyperresponsiveness in persistent asthma |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.05.2021 | ||
| 500 | |a Date Revised 19.05.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT02682862 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 650 | 7 | |a Adrenergic beta-Agonists |2 NLM | |
| 650 | 7 | |a Muscarinic Antagonists |2 NLM | |
| 650 | 7 | |a Mannitol |2 NLM | |
| 650 | 7 | |a 3OWL53L36A |2 NLM | |
| 700 | 1 | |a RuiWen Kuo, Chris |e verfasserin |4 aut | |
| 700 | 1 | |a Jabbal, Sunny |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, Rory |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology |d 1995 |g 126(2021), 5 vom: 01. Mai, Seite 597-598 |w (DE-627)NLM075127695 |x 1534-4436 |7 nnns |
| 773 | 1 | 8 | |g volume:126 |g year:2021 |g number:5 |g day:01 |g month:05 |g pages:597-598 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.anai.2021.01.032 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 126 |j 2021 |e 5 |b 01 |c 05 |h 597-598 | ||